Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.
The global Inhaled Corticosteroid market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Inhaled Corticosteroid volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inhaled Corticosteroid market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo's Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others
Segment by Application
Hospitals
Clinics
Respiratory Care Centers
Others
Table of Contents
Executive Summary
1 Inhaled Corticosteroid Market Overview
1.1 Product Overview and Scope of Inhaled Corticosteroid
1.2 Inhaled Corticosteroid Segment by Type
1.2.1 Global Inhaled Corticosteroid Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Beclomethasone Dipropionate
1.2.3 Budesonide
1.2.4 Fluticasone Inhaler Powder
1.2.5 Mometasone
1.2.6 Others
1.3 Inhaled Corticosteroid Segment by Application
1.3.1 Inhaled Corticosteroid Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Respiratory Care Centers
1.3.5 Others
1.4 Global Inhaled Corticosteroid Market by Region
1.4.1 Global Inhaled Corticosteroid Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Inhaled Corticosteroid Market Size
1.5.1 Global Inhaled Corticosteroid Revenue (2014-2025)
1.5.2 Global Inhaled Corticosteroid Production (2014-2025)
2 Global Inhaled Corticosteroid Market Competition by Manufacturers
2.1 Global Inhaled Corticosteroid Production Market Share by Manufacturers (2014-2019)
2.2 Global Inhaled Corticosteroid Revenue Share by Manufacturers (2014-2019)
2.3 Global Inhaled Corticosteroid Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Inhaled Corticosteroid Production Sites, Area Served, Product Types
2.5 Inhaled Corticosteroid Market Competitive Situation and Trends
Summary: Get latest Market Research Reports on Inhaled Corticosteroid. Industry analysis & Market Report on Inhaled Corticosteroid is a syndicated market report, published as Global Inhaled Corticosteroid Market Research Report 2019. It is complete Research Study and Industry Analysis of Inhaled Corticosteroid market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.